Market Overview

Tilray Analyst Cuts Price Target By 72% After Offering At 'The Worst Of Times'

Share:
Tilray Analyst Cuts Price Target By 72% After Offering At 'The Worst Of Times'

Cantor Fitzgerald slashed its Tilray (NASDAQ: TLRY) price target Monday in the wake of the Nanaimo, Canada-based cannabis company's pricing of a $90.4-million equity offering.

The Tilray Analyst

Pablo Zuanic maintained a Neutral rating on Tilray and lowered the price target from $17.50 to $4.90.

The Tilray Thesis

While Zuanic said he understands the need to raise funds, the analyst said he's surprised Tilray would choose "the worst of times" to price the offering. (See his track record here.)

The analyst weighed whether other cannabis companies will follow suit, and said that in the case of Aurora Cannabis (NYSE: ACB), the company is likely to rely on cost cuts, positive EBITDA and lower capex to get by. 

"The boom and bust in Canadian cannabis stocks has scared away a good number of investors," Zuanic said, but added that Cantor is comfortable with underlying trends. 

The sell-side firm has Overweight ratings on Aphria Inc (NYSE: APHA), OrganiGram Holdings Inc (NASDAQ: OGI) and Aurora; Neutral ratings on Canopy Growth Corp (NYSE: CGC) and Tilray; and an Underweight on Hexo Corp (NYSE: HEXO). 

Converted warrants and share issuance will raise the share count of Tilray stock by 38 million, representing a 37% dilution, Zuanic said. 

Cantor counted the warrants while valuing the stock, he said: "We believe if an investor has a $6 PT for TLRY, they should factor in the warrants given the strike price is $5.75."

The sum-of-the-parts valuation relies on sales multiples, the analyst said. 

“We value the domestic rec business at 4x, international med at 7x, domestic med at 2x, hemp food and CBD at 2x, and bulk at 1x; our approach yields a 12mo PT of $4.90."

TLRY Price Action

Tilray shares were trading 18.26% lower at $3.29 at the time of publication. 

Photo courtesy of Tilray. 

Latest Ratings for TLRY

DateFirmActionFromTo
Mar 2020Cantor FitzgeraldMaintainsNeutral
Mar 2020Eight CapitalDowngradesBuyNeutral
Mar 2020Cantor FitzgeraldMaintainsNeutral

View More Analyst Ratings for TLRY
View the Latest Analyst Ratings

 

Related Articles (TLRY)

View Comments and Join the Discussion!

Posted-In: Analyst Color Cannabis News Downgrades Price Target Offerings Reiteration Markets Best of Benzinga

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!